Commentary

Recently published articles about Commentary

JCP
The Demoralization Construct in Clinical Practice and Research
Commentary

March 25, 2026

It is important to acknowledge demoralization as a separate diagnosis, rather than merely a specifier, because demoralization may occur by itself, in the absence of any other disorder or...
JCP
Biography Inscribed in Biology: Diagnostic Criteria for Psychosomatic Research and the Embodiment of Lived Experience
Commentary

March 25, 2026

The DCPR framework, with its emphasis on allostatic overload, provides evidence that biography becomes biology and that lived experience is inscribed into our physiological systems.
JCP
Mind-Body Integration and East-West Fusion for Modern Medicine: Insights from the Diagnostic Criteria for Psychosomatic Research
Commentary

March 25, 2026

Clinimetrics not only lays the methodological foundation for the promotion of the DCPR but also shows potential in interdisciplinary applications.
,
JCP
Benzodiazepines as Special Risk Medications
Commentary

February 18, 2026

In light of a study examining current benzodiazepine prescribing trends, Dr Silberman comments on appropriate clinical use of these medications.
JCP
Precision Medicine for Suicide Prevention: It’s Time to Take the Next Step
Commentary

December 22, 2025

The authors recommend moving toward a precision medicine approach to suicide prevention that considers the person, their circumstances and biology, treatment delivery context, and conditions that contribute to the...
, , , et al
JCP
The Goldilocks Problem: Balancing Internal Validity with Generalizability in Clinical Trials
Commentary

November 26, 2025

The author discusses a recent analysis by Zimmerman and Snyder focusing on the generalizability of PTSD treatment trials.

Recent JCP Articles on Commentary

JCP
The Emerging Science of Clinimetrics
Commentary

September 22, 2025

Dr Guidi highlights recent developments in clinimetric assessment strategies, with particular regard to the features of clinimetric measurements, the domains of clinimetrics, and implications for clinical research and practice.
JCP
Practitioners Providing Care for Persons with Severe Mental Disorders Should Routinely Screen for Metabolic Dysfunction–Associated Steatotic Liver Disease
Commentary

September 10, 2025

Persons with severe mental illnesses should be routinely screened for MASLD as part of a psychiatric and medical assessment that includes social and economic determinants of health, risk factors...
,
JCP
How Do We Get Ketamine Safety Right? Three Questions from a Clinical Service
Commentary

July 16, 2025

The authors discuss three unanswered questions regarding ketamine, which relate to suicidality during administration, patients with substance use disorders, and REMS monitoring.
, , , et al

Recent PCC Articles on Commentary

PCC
An Update on the Future of Wilson Disease Management
Commentary

November 29, 2022

Due to Wilson disease myriad manifestations, its rarity, and its range of symptoms, differential diagnosis may be challenging, leading to delays in treatment. This Neuroscience Commentary reviews diagnostic acumen...
PCC
Gandhian Concepts on Mental Health in Contemporary COVID-19 Pandemic Times
Commentary

April 19, 2022

In this commentary, the authors discuss Gandhi’s views on mental health, especially in the context of the COVID-19 pandemic.
, , , et al
PCC
US Suicide Rates and Impact of Major Disasters
Commentary

April 12, 2022

This commentary explores the impact of major disasters on suicide rates, especially in the context of the COVID-19 pandemic.
, , , et al

Featured Commentary Research

JCP
Thirty Years of the Diagnostic Criteria for Psychosomatic Research
Systematic Review

March 25, 2026

Findings indicate that the DCPR are an essential integration to psychiatric taxonomy, particularly in the setting of medical disease, with prognostic and therapeutic implications.
, ,
JCP
What Clinicians Should Know About Alzheimer’s Treatment with Marc Agronin, MD
Podcast

March 24, 2026

Dr. Marc Agronin covers early Alzheimer's screening, biomarker diagnostics, anti-amyloid immunotherapy, and emerging treatments for cognitive decline
,
PCC
Case Report

March 24, 2026

This case highlights a rare but clinically significant dilemma: balancing essential corticosteroid replacement against neuropsychiatric toxicity.
, ,
JCP
MAOI Antidepressants: A History Being Rewritten
Commentary

November 26, 2025

Members of the International MAOI Expert Group discuss historical use of MAOIs, consider their efficacy and safety, and underscore the importance of reassessing their place in treatment algorithms.
, , , et al
JCP
Gender-Affirming Perinatal Psychiatry for Transgender and Gender Diverse People
Commentary

November 10, 2025

Considerations for providing perinatal psychiatric care to transgender and gender diverse patients are addressed
, ,
JCP
Beyond the Boxed Warning: A Call for Regulation of Psychiatry’s Most Teratogenic Drug
Commentary

October 6, 2025

The authors assert that while valproate remains invaluable for certain severe conditions, the high risk of teratogenicity means stringent safeguards are needed to regulate its use by individuals capable...
, , , et al
JCP
Why Getting Major Depression Right Matters—For Mothers, Babies, and All of Us
Commentary

September 24, 2025

Commenting on an FDA panel discussion on SSRI use during pregnancy, Dr Payne emphasizes the importance of precision when discussing treatments for mental health conditions.
JCP
Prioritizing Mental Health to Optimize Perinatal, Fetal, and Neonatal Outcomes
Commentary

September 24, 2025

Following an FDA panel discussion on use of SSRIs in pregnancy, the authors highlight the need for balanced conversations and shared decision-making accounting for the risks of untreated disease...
, , , et al
JCP
Ketamine and Esketamine: Is There a Meaningful Clinical Difference?
Commentary

September 22, 2025

The authors comment on a recent chart review by Meisner and colleagues.
,

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe